Source: ERS Lung Science Conference 2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Craig Wheelock (Stockholm, Sweden). Metabolic profiling of severe asthma: implications for phenotyping and treatment. ERS Lung Science Conference 2020

Member's Comments

No comment yet.

Related content which might interest you: Integrating fingerprints: molecular phenotyping of severe asthma Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Ykl-40 and phenotyping of severe asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Lipidomic phenotyping of severe asthma Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Potential usefulness of phenotyping in asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Improved definition of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Diagnostic approach to and phenotyping of severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 The need for asthma phenotyping Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018 The need for asthma phenotyping Source: International Congress 2017 – PG15 Asthma stratification Year: 2017 Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Transcriptome analysis of controlled and problematic severe childhood asthma Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 The pharmacogenetic aspects of corticosteroid metabolism in patients with severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 523s Year: 2006 Metabolic profiling in pulmonary diseases Source: International Congress 2019 – Metabolic alterations in lung ageing and disease Year: 2019 Biomarkers for the management of severe asthma: a survey Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021